Latest Reports

The “2025 Nonexudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of current and emerging therapies for geographic atrophy, dry AMD, and other nonexudative retinal diseases. It evaluates complement inhibitors, gene therapies, sustained-release technologies, antioxidants, and more—examining key market trends, patient economics, reimbursement dynamics, and five-year growth forecasts.  

The report also includes detailed unit and dollar demand projections, product category market shares, and profiles of 19 leading competitors with insights into their strategies and outlooks. 

Market Scope surveyed ophthalmologists and optometrists in the US and Western Europe (WE) during July and August 2025 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends. 

Ophthalmologists and optometrists from most specialties (cataract, refractive, retina, dry eye glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in the annual sponsored survey. 

An email invitation was sent on July 25, 2025, and a last call went out on Aug. 8, 2025. We received 198 total complete, unique responses—158 from the US and 40 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey. 

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server. 

The “2025 Fundus Imaging Market Report” delivers an in-depth look at one of the fastest-evolving segments of ophthalmic diagnostics, expanding on the fundus imaging coverage from Market Scope’s global Ophthalmic Diagnostic Equipment Market Report.

This specialized edition provides detailed analyses of market performance, competitive positioning, and technology trends across five product categories—fundus screeners, diagnostic fundus imaging, advanced fundus imaging, combination systems, and hand-held devices. It includes comprehensive estimates of unit sales, installed base, average selling prices, and manufacturer participation, offering a complete view of the market landscape and its growth trajectory through 2030.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report” is the definitive resource for understanding the global ophthalmic diagnostic landscape. This edition delivers in-depth analysis of the current markets for diagnostic equipment in cataract and refractive surgery, refracting and screening instruments, and emerging technologies. It also provides five-year global forecasts, along with regional and economic analyses across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report considers more than 800 devices from 115 manufacturers, covering technologies that span corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Each section includes market sizing, pricing trends, competitor market share, installed equipment base, and company profiles, giving manufacturers, investors, and eye care providers the actionable intelligence needed to navigate competitive dynamics, plan strategic growth, and anticipate technological innovation.  

The 2025 Refractive Surgery Market Report provides a comprehensive view of the global refractive and presbyopia-correcting surgical market, highlighting the trends, drivers, and opportunities shaping the next five years. The report analyzes LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging technologies poised to disrupt the market. 

It examines key participants in this segment, including prospective patients, refractive surgeons, laser centers, manufacturers of excimer and femtosecond lasers, mechanical microkeratomes, diagnostic equipment, and other presbyopia-correcting technologies.  

The report provides unit and revenue forecasts, market share analysis, and in-depth profiles of 15 leading competitors, including product portfolios, strategic positioning, company background, and outlook. 

The “2025 Glaucoma Surgical Device Market Report” provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region. 

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices—including microstents, subconjunctival shunts, canal surgery devices, and tube shunts—and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption. 

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment. 

The “2025 Ophthalmic Surgical Instruments Market Report” delivers a comprehensive analysis of the global market for reusable and disposable ophthalmic surgical instruments, with forecasts through 2030. This edition examines the latest market trends, technology shifts, and competitive dynamics shaping the future of ophthalmic surgery worldwide. It includes a comprehensive overview of ophthalmic procedures and surgical volumes, with a special focus on cataract surgery—the most frequently performed ophthalmic procedure globally.

Product demand is projected in both units and dollars, with detailed market share analysis across key product categories. The report profiles 29 leading competitors, exploring their products, strategic positioning, and growth outlook, while also identifying 83 companies actively participating in this market segment.

The 2025 China Ophthalmic Market Report delivers a comprehensive analysis of China’s rapidly evolving ophthalmic sector, analyzing the demographic trends and economic conditions that will shape the future of the market. The report offers deep insights into disease prevalence, highlights commercialized products and promising pipeline assets, and forecasts unit demand, sales revenue, and market performance through 2030. Competitive dynamics are thoroughly analyzed across product categories, and the report provides detailed profiles of 32 major competitors, their product portfolios, strategic positions, and future outlooks.  

Market Scope’s 2025 Glaucoma Disease Model offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2025 Cataract Surgical Equipment Market Report” delivers a comprehensive and forward-looking analysis of the global market, spotlighting the technologies and trends driving change in cataract surgery. This year’s edition provides detailed coverage of ultrasonic phaco systems, consumable packs and accessories, femtosecond laser-assisted cataract surgery (FLACS) platforms, and photodisruptor lasers—offering a clear view of where the market stands and where it’s headed. 

The report focuses on the 2025 market and projects growth through 2030, with forecasts in both units and dollars across key product categories. Market share analysis reveals shifts in competitive dynamics, while profiles of 21 major companies provide insights into their technologies, strategic positioning, and outlook. With new content on emerging device categories and updates to core market data, this report is essential for anyone tracking innovation and opportunity in the cataract surgical landscape.